A venture capitalist gives his perspective on the outlook for life sciences ventures amid the perfect storm of the current economic downturn.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Klausner, A. Charting a course through a perfect storm. Nat Biotechnol 27, 125–127 (2009). https://doi.org/10.1038/nbt0209-125
Issue Date:
DOI: https://doi.org/10.1038/nbt0209-125
This article is cited by
-
Is it virtuous to be virtual? The VC viewpoint
Nature Biotechnology (2009)